Harnessing Asia’s clinical trial potential
Lisa Marie Saldanha, Director, Head of Site Identification Services Asia, Quintiles and Dr Karen Wai, Senior Director, Head, Site…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Category
Archive
India, China and other emerging markets key prospects for interventional cardiac device…
Report says that manufacturers must expand capabilities and capacity through strategic partnerships in order to fulfill demand
Suven Life Sciences secures two product patents for their NCEs in the US
Will help in the treatment of disorders associated with neurodegenerative diseases
IDRI and Jubilant Chemsys extend research for TB drug discovery
The additional grant of $3.4 million will enable development of new drugs to combat tuberculosis
US FDA approves Piramal Imaging’s Neuraceq
Will help in PET imaging of beta-amyloid neuritic plaques in the brain
Urgent action needed to prevent unregulated sale of TB drugs in India: MSF
Strict regulation of first-line TB drug formulations and prescription practices in the private sector is needed in India
Novartis bags approval of Xolair
Xolair is the first and only licensed therapy in the US for the nearly 50 per cent of patients with CIU
Glenmark receives $4 million through Swiss subsidiary
Glenmark Pharmaceuticals has informed the Bombay Stock Exchange that the company through its Swiss subsidiary has received $4…
Medigene signs licence agreement with Falk Pharma
Falk Pharma will initially concentrate on development in primary biliary cirrhosis (PBC)